Abbott: FDA Approves Aveir Pacemaker For Treatment Of Patients With Slow Heart Rhythms

Abbott (ABT) announced the FDA has approved the Aveir single-chamber leadless pacemaker for the treatment of patients in the U.S. with slow heart rhythms. The Aveir leadless pacemaker is implanted directly inside the heart’s right ventricle via a minimally invasive procedure to treat slower-than-normal heart rates. The approval is supported by data from the global LEADLESS II phase 2 investigational device exemption study evaluating Aveir VR in patients with certain abnormal heart rhythms.

“The Aveir VR leadless pacemaker was designed to make the implantation and retrieval processes as seamless as possible for physicians and provide improvements over existing options,” said Randel Woodgrift, senior vice president, Cardiac Rhythm Management, Abbott.

TIM To Begin Preliminary Talks Regarding Network Integration With Open Fiber

TIM said the company has signed a non-disclosure agreement with CDP Equity S.p.A. to begin preliminary talks regarding the possible integration of TIM’s network with the network of Open Fiber, in which CDP Equity holds a 60% stake. TIM noted that the purpose of the agreement is to start negotiations with the goal of agreeing, indicatively by 30 April, on a memorandum of understanding related to the integration project.

On March 14, TIM said its Board has deliberated to mandate the Chairman and the CEO to begin formal talks with Kohlberg Kravis Roberts & Co. L.P. or KKR, beyond those already held by the advisors, in order to maximize shareholder value also in relation to other potentially interested parties.

Tesla CEO Elon Musk Tests Positive For Covid-19

Luxury electric car maker Tesla Inc. (TSLA) CEO Elon Musk said on Monday that he has “supposedly” tested positive for Covid-19 for the second time, but has no major symptoms.

“Covid-19 is the virus of Theseus. How many gene changes before it’s not Covid-19 anymore? I supposedly have it again (sigh), but almost no symptoms,” he tweeted on Monday.

The Ship of Theseus is a thought experiment that raises the question of whether an object that has had all of its components replaced remains fundamentally the same object. The concept is one of the oldest in Western philosophy, having been discussed by Heraclitus and Plato by c. 500-400 BC.

Several coronavirus variants have emerged throughout the world since the coronavirus first emerged in 2019 in Wuhan, China. According to Johns Hopkins University, over 976,000 people have died in the US from Covid-19.

Last year, Musk had questioned the accuracy of Covid-19 tests after claiming results showed he tested positive twice then negative twice on the same day.

However, Musk has been in support of vaccination. “To be clear, I do support vaccines in general & covid vaccines specifically. The science is unequivocal,” he tweeted back in April of last year.

Pre-market Movers: ISAA, TWTR, GTIM, SPI, IVDA…

The following are some of the stocks making big moves in Monday’s pre-market trading (as of 06.50 A.M. ET).

In the Green

Iron Spark I Inc. (ISAA) is up over 27% at $12.73
Twitter, Inc. (TWTR) is up over 25% at $49.43
Good Times Restaurants Inc. (GTIM) is up over 25% at $4.50
SPI Energy Co., Ltd. (SPI) is up over 25% at $3.56
Context Therapeutics Inc. (CNTX) is up over 13% at $2.72
180 Life Sciences Corp. (ATNF) is up over 12% at $2.84
Enservco Corporation (ENSV) is up over 12% at $2.79
System1, Inc. (SST) is up over 9% at $16.92
DiDi Global Inc. (DIDI) is up over 9% at $3.10
Zhihu Inc. (ZH) is up over 9% at $2.77
TMC the metals company Inc. (TMC) is up over 9% at $2.69
Expion360 Inc. (XPON) is up over 7% at $8.49
Mullen Automotive, Inc. (MULN) is up over 6% at $3.06

In the Red

Iveda Solutions, Inc. (IVDA) is down over 14% at $3.22
Ocugen, Inc. (OCGN) is down over 12% at $2.90
Blackboxstocks Inc. (BLBX) is down over 10% at $2.88
Curis, Inc. (CRIS) is down over 9% at $2.20
Hudson Capital Inc. (HUSN) is down over 8% at $2.40
Laird Superfood, Inc. (LSF) is down over 5% at $3.57

Newegg Commerce Rally Continues

Newegg Commerce, Inc. (NEGG) shares are trending up more than 10 percent on Monday morning trade, continuing an upswing since March 31. There were no corporate announcements on the day to influence the bullish trend today.

Currently, shares are at $7.17, up 10.28 percent from the previous close of $6.50 on a volume of 2,156,314. The shares have traded in a range of $4.14-$79.07 on average volume of 1,283,313 for the last 52-weeks.

Perion Network Stock Gains 10% On Strong Q1 Revenue Outlook

Shares of Perion Network Ltd. (PERI) are gaining nearly 10% on Monday morning after the company announced preliminary revenues for the first quarter, which is above Wall Street analysts’ estimates.

PERI is currently trading at $25.08, up $2.20 or 9.62%, on the Nasdaq.

For the first quarter, the company reported preliminary revenues of $125.0 million, which represents a growth of 39% compared to $89.8 million last year. Analysts polled by Thomson Reuters currently estimate revenues of $119.18 million for the quarter.

Doron Gerstel, Perion’s CEO, commented, “Perion is building an increasingly predictable and sustainable financial model, with our strong revenue ramp continuing into 2022 performance. Our results are driven by our strategic diversity of revenue streams, giving us the ability to deliver growth where the opportunities are. In the first quarter of 2022, the opportunities were clearly in our SORT innovation – and its proprietary cookieless technology – which has been used in more than 100 campaigns since launched in October 2021!”

Gerstel added that the company will updated its full-year guidance due to the “strong start of 2022 and increased visibility.” The company will report its first-quarter results on Thursday, April 28.